{
    "name": "Amgen Inc.",
    "former_names": "Applied Molecular Genetics (1980\u20131983)",
    "logo": "Amgen.svg",
    "logo_size": "250px",
    "image": "Amgenheadquarters.jpg",
    "image_size": "250px",
    "image_caption": "Headquarters in Thousand Oaks, California",
    "type": "[[Public company|Public]]",
    "ISIN": "{{ISIN|sl|=|n|pl|=|y|US0311621009}}",
    "traded_as": "{{unbulleted list|NASDAQ|AMGN|[[Nasdaq-100]] component|[[DJIA]] component|[[S&P 100]] component|[[S&P 500]] component}} {{NASDAQ|AMGN}}",
    "key_people": "{{unbulleted list|[[Robert A. Bradway]] ([[chairman]], [[President (corporate title)|president]] & [[Chief executive officer|CEO]])|[[Howard Y. Chang]] ([[chief scientific officer|CSO]])}}",
    "industry": "[[Biotechnology]]",
    "products": "{{hlist|[[Aimovig]]|[[Aranesp]]|[[Blincyto]]|[[Epogen]]|[[Anakinra|Kineret]]|[[Enbrel]]|[[Kyprolis]]|[[Neulasta]]|[[Neupogen]]|[[Nplate]]|[[Parsabiv]]|[[Prolia]]|[[Repatha]]|[[Sensipar]]/[[Mimpara]]|[[Vectibix]]|[[Xgeva]]}}",
    "revenue": "{{increase}} {{US$|33.4 billion|link|=|yes}} (2024)",
    "operating_income": "{{decrease}} {{US$|7.26 billion}} (2024)",
    "net_income": "{{decrease}} {{US$|4.09 billion}} (2024)",
    "assets": "{{decrease}} {{US$|91.8 billion}} (2024)",
    "equity": "{{decrease}} {{US$|5.88 billion}} (2024)",
    "num_employees": "28,000 (2024)",
    "foundation": "{{start date and age|1980|4|8}}",
    "location": "{{nowrap|[[Thousand Oaks, California]], U.S.}}",
    "website": "{{URL|https://amgen.com/}}"
}